Opus Genetics, Inc.
IRD
$3.61
-$0.11-2.96%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 88.81M | 59.96M | 45.09M | 30.82M | 32.43M |
| Total Receivables | 1.46M | 2.72M | 3.17M | 4.28M | 4.58M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.43M | 3.93M | 1.79M | 815.00K | 1.43M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 92.70M | 66.60M | 50.04M | 35.91M | 38.44M |
|
|
|||||
| Total Current Assets | 92.70M | 66.60M | 50.04M | 35.91M | 38.44M |
| Net Property, Plant & Equipment | 172.00K | 186.00K | 199.00K | 212.00K | 226.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 100.00K | -- | -- | -- | -- |
| Total Assets | 92.97M | 66.79M | 50.24M | 36.12M | 38.67M |
|
|
|||||
| Total Accounts Payable | 1.88M | 4.42M | 3.29M | 2.40M | 1.47M |
| Total Accrued Expenses | 5.70M | 4.90M | 4.47M | 5.10M | 6.66M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 21.00K | 15.00K | 15.00K | 21.59M | 12.07M |
| Total Other Current Liabilities | 21.00K | 15.00K | 15.00K | 21.59M | 12.07M |
| Total Current Liabilities | 7.61M | 9.34M | 7.78M | 29.09M | 20.19M |
|
|
|||||
| Total Current Liabilities | 7.61M | 9.34M | 7.78M | 29.09M | 20.19M |
| Long-Term Debt | 36.20M | 1.20M | 1.13M | 1.07M | 1.00M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 62.15M | 77.35M | 25.99M | -- | -- |
| Total Liabilities | 105.95M | 87.89M | 34.90M | 30.16M | 21.19M |
|
|
|||||
| Common Stock & APIC | 249.24M | 208.29M | 203.94M | 178.03M | 172.09M |
| Retained Earnings | -262.22M | -254.12M | -188.59M | -172.07M | -154.61M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -12.99M | -45.84M | 15.35M | 5.97M | 17.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 24.74M | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 24.74M | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.99M | -45.84M | 15.35M | 5.97M | 17.47M |
| Total Preferred Equity | -- | 24.74M | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.99M | -21.10M | 15.35M | 5.97M | 17.47M |
|
|
|||||